Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0000950170-25-002046

Options or other derivatives

  • President and CEO acquired 625,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WILSON TROY EDWARD · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 1 in the form Option to purchase common stock +625,000 625,000 D
Loading xslF345X05/ownership.xml…